Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$15.48
+5.23%today
MKT CAP
$776M
-1.8% · 1Y
Earnings History
-25.0%
-2028.8%
-2866.6%
+25920.3%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$15.48
Low
$15.00
Analyst Mean
$37.50
High
$50.00
8 analystsNone
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-1.1x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
ROE-
Debt / Equity-
Free Cash Flow$-180,674,000
Insider Ownership4.3%
Institutional Ownership52.9%
Short % of Float10.48%
Days to Cover3.4d
1 Week+8.0%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Sale | 165,150 | $15.77 | $2.60M | 2026-04-22 |
| RA CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Sale | 737,989 | $15.97 | $11.88M | 2026-04-15 |
| RA CAPITAL MANAGEMENT, L.P. | Director and Beneficial Owner of more than 10% of a Class of Security | Sale | 849,257 | $16.51 | $14.52M | 2026-04-06 |
| RA CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Sale | 400,408 | $25.12 | $10.37M | 2025-10-30 |
| RA CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Sale | 221,166 | $28.01 | $6.20M | 2025-10-27 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | institution | 9.97% | $0.09B | +172.66% | 2025-12-31 |
| FCPM III Services B.V. | institution | 6.68% | $0.06B | +852.84% | 2025-12-31 |
| Frazier Life Sciences Management, L.P. | institution | 4.69% | $0.04B | +100.00% | 2025-12-31 |
| FMR, LLC | institution | 4.66% | $0.04B | +968.11% | 2025-12-31 |
| VR Adviser, LLC | institution | 3.59% | $0.03B | +288.78% | 2025-12-31 |
| Paradigm Biocapital Advisors LP | institution | 3.23% | $0.03B | +100.00% | 2025-12-31 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | fund | 2.83% | $0.03B | +0.00% | 2026-03-31 |
| Great Point Partners LLC | institution | 2.53% | $0.02B | +100.00% | 2025-12-31 |
| Nextbio Capital Management LP | institution | 1.85% | $0.02B | +100.00% | 2025-12-31 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | fund | 1.80% | $0.02B | +100.00% | 2026-03-31 |
| Caligan Partners, LP | institution | 1.71% | $0.02B | +100.00% | 2025-12-31 |
| Vanguard Group Inc | institution | 1.42% | $0.01B | +632.25% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 0.88% | $0.01B | +602.05% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.33% | $0.00B | +624.22% | 2025-12-31 |
| BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio | fund | 0.21% | $0.00B | -2.12% | 2026-02-28 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.15% | $0.00B | -7.85% | 2026-02-28 |
| John Hancock Funds II-Small Cap Dynamic Growth Fund | fund | 0.12% | $0.00B | +100.00% | 2026-03-31 |
| iShares Trust-iShares Core S&P Total U.S. Stock Market ETF | fund | 0.12% | $0.00B | -27.96% | 2026-03-31 |
| Direxion Shares ETF Trust-Direxion Daily S&P Biotech Bull 3X ETF | fund | 0.10% | $0.00B | +7.63% | 2026-04-30 |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | fund | 0.10% | $0.00B | +62.94% | 2026-03-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for VOR.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.